Option Care Health (NASDAQ:OPCH) Sees Large Volume Increase – What’s Next?

Option Care Health, Inc. (NASDAQ:OPCH) shares saw unusually-strong trading volume on Friday . Approximately 3,834,392 shares were traded during trading, an increase of 164% from the previous session’s volume of 1,450,343 shares.The stock last traded at $24.03 and had previously closed at $23.04.

Analysts Set New Price Targets

Several research firms have commented on OPCH. Barrington Research dropped their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research report on Thursday. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their price target for the company from $43.00 to $29.00 in a research report on Wednesday. JMP Securities raised their target price on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and reduced their price target for the company from $38.00 to $26.00 in a research report on Thursday. Finally, Truist Financial reduced their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $31.60.

Option Care Health Trading Up 3.4 %

The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.36 and a current ratio of 1.73. The firm has a market capitalization of $4.08 billion, a P/E ratio of 19.36, a PEG ratio of 1.79 and a beta of 1.29. The firm has a 50 day simple moving average of $30.65 and a two-hundred day simple moving average of $29.97.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. The business had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.22 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. Equities research analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Elizabeth Quadros Betten sold 47,531 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the sale, the director now owns 21,339 shares in the company, valued at $663,429.51. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the transaction, the director now directly owns 21,339 shares in the company, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the sale, the chief financial officer now owns 247,317 shares in the company, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.64% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Option Care Health

Institutional investors and hedge funds have recently made changes to their positions in the business. Massachusetts Financial Services Co. MA purchased a new stake in shares of Option Care Health in the 2nd quarter valued at about $68,003,000. Magnetar Financial LLC raised its position in Option Care Health by 124.8% during the second quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock valued at $68,750,000 after purchasing an additional 1,377,929 shares in the last quarter. Duquesne Family Office LLC raised its holdings in shares of Option Care Health by 172.8% during the 2nd quarter. Duquesne Family Office LLC now owns 1,871,818 shares of the company’s stock valued at $51,849,000 after buying an additional 1,185,613 shares in the last quarter. Hood River Capital Management LLC raised its stake in shares of Option Care Health by 77.2% during the second quarter. Hood River Capital Management LLC now owns 1,729,029 shares of the company’s stock worth $47,894,000 after acquiring an additional 753,208 shares in the last quarter. Finally, Westfield Capital Management Co. LP boosted its stake in shares of Option Care Health by 15.4% in the 1st quarter. Westfield Capital Management Co. LP now owns 5,171,385 shares of the company’s stock valued at $173,448,000 after purchasing an additional 688,653 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.